The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

(Reuters) - The U.S. government will consider opportunities to "bring greater transparency" for the Medicare drug price ...

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...

Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Minnesota Senator Amy Klobuchar is urging the Trump administration to continue negotiating lower prescription drug prices for ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...